PF-05105679

N/A

Report date: 2023/07/10 20:00:27
NME

Base Information

Drug NamePF-05105679
Drug Alias NamePF-5105679PF-05105679
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 antagonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of Vienna
Inactive CompaniesPfizer Inc
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A